D-0307-2021 Class III Terminated

Recalled by Edge Pharma, LLC — Colchester, VT

FDA drug recall D-0307-2021 was initiated by Edge Pharma, LLC on Dec 22, 2020 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date The recall status is terminated (terminated Jun 10, 2021). Affected quantity: 60 syringes.

Recall details

Product Type
Drugs
Report Date
Mar 24, 2021
Initiation Date
Dec 22, 2020
Termination Date
Jun 10, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
60 syringes

Product description

Epinephrine/Lidocaine HCl, Sterile Ophthalmic Solution for Injection, 0.8 mL per syringe, Single Use Syringe, 0.025%/0.75%, Rx only, Edge Pharma LLC 856 Hercules Dr. Colchester, VT 05446, NDC 05446-0863-01

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Distribution pattern

PA only

Code information

Lot #: 10-2020-13@8, exp. date 12/03/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0307-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0307-2021. Report a data issue: hello@regdatalab.com.